EYE National Vision Holdings, Inc. NASDAQ · United States

National Vision Holdings (EYE) news

National Vision Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker EYE, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest National Vision Holdings news

We have not published a story on National Vision Holdings yet. When there is news, it will appear here.

National Vision Holdings annual financials

Line	FY ended Jan 3, 2026	FY ended Dec 28, 2024
Revenue	$1.99 billion	$1.82 billion
Net income (loss)	$29.6 million	-$28.5 million
Cash from operations	$146.3 million	$133.6 million
Cash and equivalents	$38.7 million	$73.9 million

Latest balance sheet, Jul 4, 2026 (10-Q): cash and equivalents $36.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about National Vision Holdings

What is the ticker symbol of National Vision Holdings?

National Vision Holdings, Inc. trades under the ticker EYE on NASDAQ.

Where is National Vision Holdings listed?

National Vision Holdings, Inc. is listed on NASDAQ.

Which country or territory is National Vision Holdings listed under?

Our directory records National Vision Holdings, Inc. under United States.

Does aibio.space cover National Vision Holdings?

aibio.space lists National Vision Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was National Vision Holdings's revenue last year?

$1.99 billion for the fiscal year ended Jan 3, 2026, as reported to the SEC.

Is National Vision Holdings profitable?

National Vision Holdings, Inc. reported net income of $29.6 million for the fiscal year ended Jan 3, 2026, and generated $146.3 million of cash from operations, per its annual report to the SEC.

How much cash does National Vision Holdings have?

$36.0 million in cash at Jul 4, 2026, per its 10-Q.

Investor discussion: National Vision Holdings

Members talk about National Vision Holdings (EYE). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:EYE on TradingView.

Listing details

Company: National Vision Holdings, Inc.
Ticker: EYE
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction